日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual CDK4/6-PI3K/mTOR inhibition reinforces cytostatic programs and tumor control in preclinical models of primary and metastatic osteosarcoma

双重 CDK4/6-PI3K/mTOR 抑制可增强原发性和转移性骨肉瘤临床前模型中的细胞抑制程序和肿瘤控制。

Barghi, Farinaz; Saadatzadeh, M Reza; Dobrota, Erika A; Shannon, Harlan E; Bailey, Barbara J; Young, Courtney; Malko, Rada; Justice, Ryli; Riyahi, Niknam; Davis, Christopher; Bijangi-Vishehsaraei, Khadijeh; Kreklau, Keiko; Stevens, Lauren K; Koenig, Jenna; Sulayman, Shirzat; Liu, Sheng; Wan, Jun; Trowbridge, Melissa A; Coy, Kathy; Kennedy, Felicia M; Sinn, Anthony L; Just, Marissa; Jackson, Kyle W; Sandusky, George; Wurtz, L Daniel; Collier, Christopher D; Mitchell, Dana; Seiden, Emily E; Greenfield, Edward M; Doud, Emma; Mosley, Amber; Angus, Steven P; Ferguson, Michael J; Pandya, Pankita H; Pollok, Karen E

Reframing RB Tumor Suppressor Dysfunction as a Therapeutic Vulnerability in Cancer

将RB肿瘤抑制因子功能障碍重新定义为癌症治疗中的一个弱点

Malko, Rada; Shannon, Harlan E; Dobrota, Erika A; Kreklau, Keiko E; Stevens, Lauren K; Jackson, Kyle W; Saadatzadeh, M Reza; Pandya, Pankita H; Pollok, Karen E

DLK1 Distinguishes Subsets of NF1-Associated Malignant Peripheral Nerve Sheath Tumors with Divergent Molecular Signatures.

DLK1 可区分具有不同分子特征的 NF1 相关恶性周围神经鞘瘤亚型

Mitchell Dana K, Brewster Kylee, Makri Stavriani C, Khan Jaffar, Albright Eric A, Horvai Andrew, Mang Henry, Lu Qingbo, Dixon Shelley A H, White Emily, Saadatzadeh Mohammad Reza, Bijangi-Vishehsaraei Khadijeh, Gampala Silpa, Hickey Brooke E, Leffew Hannah, Li Xiaohong, Jiang Li, Ciesielski Marisa D, Bessler Waylan K, Collier Christopher D, Cohen-Gadol Aaron, Fishel Melissa L, Pratilas Christine A, Pollok Karen E, Angus Steven P, Rhodes Steven, Clapp Wade

Therapeutic Targeting of BET Proteins in Sarcoma

肉瘤中BET蛋白的治疗靶向治疗

Riyahi, Niknam; Malko, Rada; Shannon, Harlan E; Jackson, Kyle W; Justice, Ryli E; Kreklau, Keiko; Saadatzadeh, M Reza; Pollok, Karen E; Pandya, Pankita H

Probiotic preserving extract supplementation as a novel attitude in managing diabetes mellitus

益生菌保存提取物补充剂作为糖尿病管理的一种新方法

Saadatzadeh, Afrooz; Emamifar, Seyed Mohammad Kazem; Mard, Seyyed Ali; Ahangarpour, Akram; Angali, Kambiz Ahmadi; Mehdialamdarlou, Sanaz

Screening FDA-Approved Oncology Drugs with Three-Dimensional Spheroids Identifies Romidepsin as a Therapeutic Candidate for Osteosarcoma

利用三维球体筛选FDA批准的肿瘤药物,发现罗米地辛是骨肉瘤的候选治疗药物。

Emily E Seiden ,Spencer M Richardson,Leah A Everitt,Gabrielle J Knafler,Alyssa L Walker,Venetia A Whiteside,Divya Pillutla,Shrey Ramnath,Gavin P Kinsella,Piper A Wilburn,James D Buschbach,Deep A Gandhi,M Reza Saadatzadeh ,L Daniel Wurtz,Patrick J Getty,Sheldon L Padgett,Rance M Gamblin,Michael O Childress ,Christopher M Fulkerson ,Maegan L Capitano,Karen E Pollok ,Christopher D Collier # ,Edward M Greenfield #

Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities

增强抗肿瘤潜力:低强度振动可抑制骨肉瘤进展并增强 MSCs 的肿瘤抑制能力

Xue Xiong, Qingji Huo, Kexin Li, Changpeng Cui, Chunyi Chang, Charles Park, BonHeon Ku, Chin-Suk Hong, HeeChang Lim, Pankita H Pandya, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Chien-Chi Lin, Melissa A Kacena, Karen E Pollok, Andy Chen, Jing Liu, William R Thompson, Xue-Lian Li, Bai-Yan Li,

EXTH-46. TESTING PRECISION GENOMICS-GUIDED THERAPY IN A MODEL OF ANAPLASTIC PLEOMORPHIC XANTHOASTROCYTOMA: DUAL INHIBITION OF CDK4/6 AND MEK

EXTH-46. 在间变性多形性黄色星形细胞瘤模型中测试精准基因组学指导疗法:CDK4/6 和 MEK 的双重抑制

Meyer, Vera; Wu, Bo; Ram, Arthur F J; Koenig, Jenna; Saadatzadeh, M Reza; Bailey, Barbara J; Pandya, Pankita H; Dobrota, Erika A; Coy, Kathryn; Kennedy, Felicia M; Sinn, Anthony L; Tailor, Jignesh K; Angus, Steven P; Damayanti, Nur P; Pollok, Karen E

Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins

骨肉瘤富集的转录本反而产生抑制骨肉瘤的细胞外蛋白

Kexin Li, Qingji Huo, Nathan H Dimmitt, Guofan Qu, Junjie Bao, Pankita H Pandya, M Reza Saadatzadeh, Khadijeh Bijangi-Vishehsaraei, Melissa A Kacena, Karen E Pollok, Chien-Chi Lin, Bai-Yan Li, Hiroki Yokota

Establishment and characterization of patient-derived xenograft of a rare pediatric anaplastic pleomorphic xanthoastrocytoma (PXA) bearing a CDC42SE2-BRAF fusion

携带 CDC42SE2-BRAF 融合的罕见儿童间变性多形性黄色星形细胞瘤 (PXA) 患者来源异种移植的建立和表征

Nur P Damayanti #, M Reza Saadatzadeh #, Erika Dobrota, Josue D Ordaz, Barbara J Bailey, Pankita H Pandya, Khadijeh Bijangi-Vishehsaraei, Harlan E Shannon, Anthony Alfonso, Kathy Coy, Melissa Trowbridge, Anthony L Sinn, Zhong-Yin Zhang, Rosa I Gallagher, Julia Wulfkuhle, Emanuel Petricoin, Angela M